Side-by-side comparison of AI visibility scores, market position, and capabilities
TMRW Life Sciences builds AI-powered storage and tracking technology for IVF clinics that ensures embryo identity through automated monitoring and chain-of-custody verification.
TMRW Life Sciences is a medical technology company founded in 2018 that has raised $75M to build automated storage and tracking systems for fertility clinics that protect the identity and safety of eggs and embryos during IVF treatment. The company's core product is an intelligent storage system that uses barcoded vitrification devices, automated ID verification at every handling step, and continuous environmental monitoring to ensure that embryos are stored at optimal conditions and that identity errors — which can have devastating consequences — are eliminated. TMRW uses machine learning to analyze embryo images and storage conditions, providing fertility clinics with quality control data that was previously impossible to collect at this scale. The company has deployed systems at leading fertility clinic networks across the United States and internationally. TMRW addresses a critical patient safety need as IVF volumes have grown dramatically and clinics have struggled to maintain chain-of-custody integrity with manual processes. The platform also provides operational efficiency benefits for clinic staff and generates data that can be used to improve embryo culture protocols and predict embryo viability.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.